SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-288194
Filing Date
2015-08-12
Accepted
2015-08-12 16:54:25
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d940847d10q.htm 10-Q 581654
2 EX-10.1 d940847dex101.htm EX-10.1 171054
3 EX-31.1 d940847dex311.htm EX-31.1 8641
4 EX-31.2 d940847dex312.htm EX-31.2 8610
5 EX-32.1 d940847dex321.htm EX-32.1 5316
12 GRAPHIC g940847new17.jpg GRAPHIC 65727
  Complete submission text file 0001193125-15-288194.txt   3051800

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sage-20150630.xml EX-101.INS 369243
7 XBRL TAXONOMY EXTENSION SCHEMA sage-20150630.xsd EX-101.SCH 33827
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20150630_cal.xml EX-101.CAL 36478
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20150630_def.xml EX-101.DEF 141469
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20150630_lab.xml EX-101.LAB 282770
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20150630_pre.xml EX-101.PRE 211508
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 151047651
SIC: 2834 Pharmaceutical Preparations